Ke Jiang

110 Ganhe Road
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Prolactin-Linked Plasma Cell-Macrophage Immune Phenotype in Synchronous Bilateral Plasma Cell Mastitis: A Two-Center Prediction Study with Tissue Correspondence.

Prolactin-Linked Plasma Cell-Macrophage Immune Phenotype in Synchronous Bilateral Plasma Cell Mastitis: A Two-Center Prediction Study with Tissue Correspondence.

Journal: International journal of women's health
Published: May 26, 2026

Navigating the diagnostic pitfalls of cystic and solid breast masses: a comparative case report of metaplastic carcinoma and benign lesions.

Navigating the diagnostic pitfalls of cystic and solid breast masses: a comparative case report of metaplastic carcinoma and benign lesions.

Journal: Frontiers in oncology
Published: March 06, 2026

GLDC, PYCR3, and PID1: Potential biomarkers and therapeutic targets for comorbid breast cancer and depression.

GLDC, PYCR3, and PID1: Potential biomarkers and therapeutic targets for comorbid breast cancer and depression.

Journal: Journal of affective disorders
Published: February 15, 2026

Sanhua essential oil exerts antidepressant effects in breast cancer-related depression by modulating metabolic pathways.

Sanhua essential oil exerts antidepressant effects in breast cancer-related depression by modulating metabolic pathways.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 16, 2025

Case Report: Advanced breast invasive ductal carcinoma with erysipeloid cutaneous metastasis misdiagnosed as erysipelas.

Case Report: Advanced breast invasive ductal carcinoma with erysipeloid cutaneous metastasis misdiagnosed as erysipelas.

Journal: Frontiers in oncology
Published: November 27, 2024

The Efficacy of Moxibustion for Breast Cancer Patients with Chemotherapy-Induced Myelosuppression during Adjuvant Chemotherapy: A Randomized Controlled Study.

The Efficacy of Moxibustion for Breast Cancer Patients with Chemotherapy-Induced Myelosuppression during Adjuvant Chemotherapy: A Randomized Controlled Study.

Journal: Evidence-based complementary and alternative medicine : eCAM
Published: August 02, 2020

The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial.

The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial.

Journal: Trials
Published: May 11, 2020

Identification by Comprehensive Bioinformatics Analysis of KIF15 as a Candidate Risk Gene for Triple-Negative Breast Cancer.

Identification by Comprehensive Bioinformatics Analysis of KIF15 as a Candidate Risk Gene for Triple-Negative Breast Cancer.

Journal: Cancer management and research
Published: May 09, 2020

Unraveling Heterogeneity of Tumor Cells and Microenvironment and Its Clinical Implications for Triple Negative Breast Cancer.

Unraveling Heterogeneity of Tumor Cells and Microenvironment and Its Clinical Implications for Triple Negative Breast Cancer.

Journal: Frontiers in oncology
Published: April 30, 2020

Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.

Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.

Journal: Current molecular medicine
Published: August 22, 2018

Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer.

Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer.

Journal: Oncotarget
Published: December 27, 2016

Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.

Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.

Journal: International immunopharmacology
Published: July 15, 2016
Showing 1-12 of 13

Last Updated: 09/26/2026